Megestrol Acetate
Product Images NDC 60432-126

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Megestrol Acetate (NDC 60432-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Morton Grove Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

A697441b Aafb 4be7 Bc29 B16071fed1cf 01

Chemical structure of megestrol acetate, as labeled in the image. The diagram depicts the molecular framework of the active ingredient megestrol acetate, USP, showing its atoms and bonds.*

FDA Label Image

A697441b Aafb 4be7 Bc29 B16071fed1cf 02

Two line graphs titled Trial 1 and Trial 2 depict mean weight change in pounds over 12 weeks for different doses of Megestrol Acetate (100 mg, 400 mg, 800 mg) and placebo. Both show increasing weight gain with higher doses compared to placebo, which shows little to no change.*

FDA Label Image

A697441b Aafb 4be7 Bc29 B16071fed1cf 03

Packaging label for Megestrol Acetate oral suspension, USP 40 mg/mL by Morton Grove Pharmaceuticals, Inc. The label indicates it is a lemon-lime flavored oral suspension with 40 mg of micronized megestrol acetate per mL. It comes in a 1 pint (480 mL) sealed bottle. The design includes storage instructions, a barcode, and manufacturing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.